Rigel Pharmaceuticals (RIGL) Inventory (2018 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Inventory of $11.7 million for Q1 2026, up 150.1% year-over-year from $4.7 million in Q1 2025, and up 1.27% quarter-over-quarter from $11.5 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Inventory (2018 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Inventory history runs 9 years deep, the most recent figure standing at $11.7 million for Q1 2026.
- In Q1 2026, Inventory rose 150.1% year-over-year to $11.7 million; the TTM figure through Mar 2026 stood at $11.7 million (up 150.1% YoY), while the FY2025 annual figure was $11.5 million, up 91.7% from the prior year.
- Inventory for Q1 2026 stood at $11.7 million, up from $11.5 million in the prior quarter.
- The five-year high for Inventory was $13.3 million in Q3 2025, with the low at $4.7 million in Q1 2025.
- The 5-year median for Inventory is $7.1 million (2022), against an average of $8.2 million.
- The sharpest annual moves came in 2024 and 2025: Inventory tumbled 40.61% in 2024, then surged 178.07% in 2025.
- Rigel Pharmaceuticals' Inventory stood at $9.1 million in 2022, then tumbled by 39.44% to $5.5 million in 2023, then gained by 8.69% to $6.0 million in 2024, then soared by 91.7% to $11.5 million in 2025, then climbed by 1.27% to $11.7 million in 2026.
- Business Quant data shows RIGL's Inventory at $11.7 million in Q1 2026, $11.5 million in Q4 2025, and $13.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 14.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.37 Mn |
| Mar 31, 2026 | 11.65 Mn |
| Dec 31, 2025 | 11.51 Mn |
| Sep 30, 2025 | 13.30 Mn |
| Jun 30, 2025 | 10.42 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 4.78 Mn |
| Jun 30, 2024 | 8.06 Mn |
| Mar 31, 2024 | 6.58 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 6.11 Mn |
| Jun 30, 2023 | 10.78 Mn |
| Mar 31, 2023 | 11.08 Mn |
| Dec 31, 2022 | 9.12 Mn |
| Sep 30, 2022 | 7.12 Mn |
| Jun 30, 2022 | 6.22 Mn |
| Mar 31, 2022 | 6.76 Mn |
| Dec 31, 2021 | 6.62 Mn |
| Sep 30, 2021 | 7.04 Mn |